Advertisement

Topics

Modex Company Profile

09:06 EST 18th November 2017 | BioPortfolio

Modex Therapeutics is a publicly listed Swiss biotechnology company that is developing therapeutic products for the treatment of skin wounds and skin diseases. Founded in 1996, Modex originally focused on the development of two cell-based technologies - EpiDex™ and BioDelivery. Recognizing new opportunities in dermatology, Modex is expanding its product development pipeline to include new therapeutic agents for the treatment of a wide range of skin diseases.

The focus on dermatology, with its large unmet medical needs, is a natural progression for Modex and is founded on the success of EpiDex™, a groundbreaking product for the treatment of hard-to-heal chronic skin ulcers. Core competences in biotechnology and strengths in clinical development enable Modex to develop innovative products for the treatment of skin disorders and disease. The goal is to become a leading dermatology company by progressively establishing a product pipeline for diverse indications.



Modex currently employs 55 people. The company has research, product development and manufacturing laboratories at its headquarters in Lausanne, Switzerland, and at its subsidiary in Leipzig, Germany. The company raised CHF 74 million (US$ 43 million) in June 2000 in an initial public offering. Registered shares of Modex Therapeutics (MDXN) are traded on the SWX New Market.

Location

18-20, Avenue de Sévelin
Lausanne
CH-1004
Switzerland

Contact

Phone: +41 21 620 60 00
Fax: +41 21 620 60 60
Email: drjones@mdxn.ch


News Articles [1 Associated News Articles listed on BioPortfolio]

Modex unleashes Blockchain App store for Smart Contracts

Modex / Modex unleashes Blockchain App store for Smart Contracts . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Modex

Modex Therapeutics is a publicly listed Swiss biotechnology company that is developing therapeutic products for the treatment of skin wounds and skin diseases. Founded in 1996, Modex originally focuse...

More Information about "Modex" on BioPortfolio

We have published hundreds of Modex news stories on BioPortfolio along with dozens of Modex Clinical Trials and PubMed Articles about Modex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Modex Companies in our database. You can also find out about relevant Modex Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record